Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenyang Jinlong Pharmaceutical is a Chinese pharmaceutical company specializing in the development and production of Traditional Chinese Medicine (TCM) and biochemical drugs, with a primary focus on oncology. The company is best known for its flagship product, Jinlong Capsule (金龙胶囊), an animal-derived biologic preparation made from fresh snake extracts used as an adjuvant therapy for various malignancies, including liver and digestive tract cancers. Shenyang Jinlong operates large-scale, GMP-certified manufacturing facilities in Shenyang and maintains a significant presence in the Chinese domestic hospital market. Its business model integrates research, production, and sales, focusing on immunomodulatory and anti-tumor therapies derived from natural sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenyang Jinlong Pharmaceutical.